Daphne Lo

Daphne Lo

Auto-generated profile, based on publicly available information

Daphne Lo

Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Heart & Lung
Verified
Journal Article
Closed access
HLHillary Lum
Hillary Lum
DLDaphne Lo
Daphne Lo
SHStephanie A Hooker
Stephanie A Hooker
DBDavid B. Bekelman
David B. Bekelman

1 October 2011 in Expert Review of Neurotherapeutics
Verified
Journal Article
Closed access
DLDaphne Lo
Daphne Lo
GGGeorge T Grossberg
George T Grossberg
The term 'dementia' encompasses a number of neurodegenerative diseases of which Alzheimer's disease (AD) is the most common. Prior to 2003, cholinesterase inhibitors, such as donezepil, were the only class of drugs approved to treat mild-to-moderate AD. In 2003, memantine became the first drug approved by the US FDA to treat moderate-to-severe AD. Currently, both memantine and donepezil are FDA approved for the treatment of moderate-to-severe AD. This article examines the pharmacologic profile of memantine, evidence for memantine's efficacy in moderate-to-severe AD and other dementias, its novel use in other neuropsychiatric disorders and future implications and research directions for memantine.

30 November 2010 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
DLDaphne Lo
Daphne Lo
MPMiguel A. Paniagua
Miguel A. Paniagua
DTDavid R. Thomas
David R. Thomas

1 January 2016
Verified
Book Chapter
Closed access
WAWajiha Z. Akhtar
Wajiha Z. Akhtar
SASteven M. M Albert
Steven M. M Albert
EAElena M. Andresen
Elena M. Andresen
JBJudith C. Barker
Judith C. Barker
JBJane Bear-Lehman
Jane Bear-Lehman
MWMirtha M. Whaley
Mirtha M. Whaley